Skip to content

Clinical trials

Phase 3 Gastroesophageal Reflux trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 3 Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20042
20052
20066
20072
20083
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Takeda4
Wyeth is now a wholly owned subsidiary of Pfizer3
Eisai Inc.2
Aviel Roy-Shapira, M.D.1
Cinclus Pharma Holding AB1
Cogentus Pharmaceuticals1
Nycomed1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux21
Peptic Ulcer2
Acute Coronary Syndrome1
Cerebrovascular Disorders1
Chest Pain1
Coronary Artery Disease1
Coronary Thrombosis1
Duodenal Obstruction1
Duodenal Ulcer1
Dyspepsia1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.